Advertisement
Advertisement
RDY
Dr. Reddy's Laboratories Limited - ADR
13.63
USDSponsored
+0.11
+0.81%
May 29, 16:00 UTC -4
Closed
After-Market
13.66
+0.03
+0.22%
RDY Earnings Reports
Positive Surprise Ratio
RDY beat 23 of 41 last estimates.
56%
Next Report
Date of Next Report
Jul 21, 2026
Estimate for Q1 27 (Revenue/ EPS)
$81.02B
/$9.79
Implied change from Q4 26 (Revenue/ EPS)
+7.36%
/+269.43%
Implied change from Q1 26 (Revenue/ EPS)
-5.49%
/-42.48%
Dr. Reddy's Laboratories Limited - ADR earnings per share and revenue
On May 12, 2026, RDY reported earnings of 2.65 USD per share (EPS) for Q4 26, missing the estimate of 11.40 USD, resulting in a -76.76% surprise. Revenue reached 75.46 billion, compared to an expected 84.10 billion, with a -10.27% difference. The market reacted with a +4.25% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 3 analysts forecast an EPS of 9.79 USD, with revenue projected to reach 81.02 billion USD, implying an increase of 269.43% EPS, and increase of 7.36% in Revenue from the last quarter.
FAQ
What were Dr. Reddy's Laboratories Limited - ADR's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Dr. Reddy's Laboratories Limited - ADR reported EPS of $2.65, missing estimates by -76.76%, and revenue of $75.46B, -10.27% below expectations.
How did the market react to Dr. Reddy's Laboratories Limited - ADR's Q4 2026 earnings?
The stock price moved up 4.25%, changed from $12.46 before the earnings release to $12.99 the day after.
When is Dr. Reddy's Laboratories Limited - ADR expected to report next?
The next earning report is scheduled for Jul 21, 2026.
What are the forecasts for Dr. Reddy's Laboratories Limited - ADR's next earnings report?
Based on 3
analysts, Dr. Reddy's Laboratories Limited - ADR is expected to report EPS of $9.79 and revenue of $81.02B for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement